Purchase Order 75F40122P00180

The Department of Health and Human Services Food and Drug Administration awarded a $158,246.16 firm fixed price delivery order contract to Qiagen, LLC for extraction and libraries kits and materials compatible with Qiagen's QIACube robots. These products will be used by the FDA for sequencing RNA and DNA from samples as part of their automated nucleic acid analyses performed on the QIACube platform. The place of performance will be in New Carrollton, Maryland. Qiagen, LLC is a subsidiary of...

The Food and Drug Administration awarded a $60,319.93 firm fixed-price purchase order to Qiagen, LLC for tests related to array-based gene expression. The contract, with an ultimate completion date of August 24, 2026, was awarded on July 22, 2025, without a set-aside designation. Work will be performed in Silver Spring, Maryland. This procurement supports FDA's regulatory and scientific activities, which rely on advanced molecular diagnostics and genetic testing capabilities to evaluate new...

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Qiagen, LLC for an annual service agreement for nucleic acid extraction equipment, valued at $10,410.00, with an award date of May 15, 2020 and completion date of May 14, 2021. Work is performed in Germantown, Maryland. The order is priced on a firm fixed price basis with no set-aside designation.</p>

The National Institute of Allergy and Infectious Diseases awarded a $17,013.02 firm fixed-price purchase order to Qiagen, LLC for the QIASEQ FastSelect 5S/16S/23S Kit (384). This contract, awarded on September 16, 2021, with an ultimate completion date of September 24, 2021, represents a straightforward procurement of specialized molecular biology reagents used for ribosomal RNA depletion and sample preparation in next-generation sequencing applications. The award includes no set-aside...

This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS), to Qiagen, LLC, a subsidiary of the multinational biotechnology company Qiagen N.V. The $41,687.04 firm-fixed-price purchase order is for the QIAAMP Viral RNA Mini Kit (250), which is used for the extraction and purification of viral RNA. This award is not associated with any set-aside designation. Qiagen has...

The Department of Health and Human Services Food and Drug Administration awarded a Firm Fixed Price Delivery Order contract to Qiagen, LLC, a division of Qiagen N.V., for the purchase of molecular biology reagents. The $149,040.91 contract has a completion date of September 26, 2022. Qiagen is an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academics, and has previously provided products and services like DNA/RNA extraction kits,...

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Qiagen, LLC for a PCR system on March 19, 2020, with a ceiling value of $16,503.50 and ultimate completion date of April 16, 2020. Performance took place in Germantown, Maryland. The order was priced on a firm fixed-price basis with no set-aside applied.</p>

This is a federal contract award to Qiagen, LLC, a division of the biotechnology company Qiagen N.V. The contract, awarded by the Food and Drug Administration (FDA), a civilian agency within the Department of Health and Human Services (HHS), has a ceiling value of $107,401.82 and is a firm fixed-price purchase order with an ultimate completion date of August 22, 2019. The contract provides for the addition of funding to an original requisition, without any set-aside designation. Qiagen, a...

The U.S. federal government awarded a Firm Fixed Price Purchase Order contract worth $22,732.35 to Qiagen, LLC, a division of the international company Qiagen N.V., for the provision of DNA isolation kits. The contract has an ultimate completion date of June 1, 2018 and was awarded on May 3, 2018 by the Acquisitions agency, which is a civilian agency. Qiagen, LLC is a foreign-owned, for-profit manufacturer that has provided various products and services to support federal agencies' biomedical...

The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order to Qiagen, LLC for a PYROMARK Q48 SYSTEM with a completion date of July 20, 2019 and a potential value of $139,884.28. Qiagen, LLC is a division of Qiagen N.V., an international provider of sample and assay technologies. Qiagen has provided a range of products and services, including DNA/RNA extraction kits, next-generation sequencing, and precision medicine...